TBRG

Earlier this month, TruBridge, Inc. TBRG reported its first-quarter 2026 results. The company delivered adjusted earnings per share (EPS) of 50 cents, up 63.9% year over year, and topped the Zacks Consensus Estimate by 15.7%. However, revenues declined 1.1% from the prior year period to $86.27 million, missing the consensus mark by 3.6%. The announcement came nearly two weeks after another major development for the company. On April 23, TruBridge announced that Inventurus Knowledge Solutions, Inc. (“IKS”), the U.S. subsidiary of Inventurus Knowledge Solutions Limited (“IKS Health”), has entered into a definitive agreement to acquire the former. With TruBridge’s expertise in serving rural and community hospitals through revenue cycle management and electronic health record (EHR) solutions, the combined company aims to strengthen local healthcare systems and enhance care delivery across the ambulatory and acute care continuum. Under the terms of the agreement, TBRG shareholders will receive $26.25 in cash for each share of common stock, valuing the company at roughly 557 million. The stock closed yesterday’s session at $25.90, implying another 1.4% upside potential to the offer price. The deal has already received approval from the boards of directors of IKS Health, IKS, and TruBridge, and is expected to close during the third calendar quarter of 2026. On May 11, TruBridge stock hit a fresh 52-week high at $26.51 intraday. So far this year, shares have gained 17.4%, outperforming the industry’s 23.7% plunge and the Medical sector’s 6.6% drop. The S&P 500 composite has returned 9.1% in the same time frame. TBRG also demonstrated impressive performance in comparison to its peers McKesson Corp. MCK and Waystar Holding Corp. WAY, whose shares have declined 6.6% and 42.6%, respectively. Image Source: Zacks Investment Research In first-quarter 2026, Patient Care revenues increased 6% year over year, fueled by revenues from new SaaS contracts, migrations to SaaS arrangements and the timing of annual licenses. Growth was partially offset by the sunsetting of the Centriq product. TruBridge discontinued support and services of the web-based acute-care EHR platform as of Dec. 31, 2024, except for a few customers who have not migrated to another EHR platform. Excluding Centric, revenues rose 8% over the prior-year period.Recurring revenues represented 87% of total segment...

MOBILE, Ala., May 08, 2026--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) ("TruBridge"), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the first quarter ended March 31, 2026. Recent Developments As previously announced on April 23, 2026, TruBridge announced a definitive agreement whereby TruBridge, Inc. will be acquired by Inventurus Knowledge Solutions, Inc. ("IKS"), the U.S. subsidiary of Inventurus Knowledge Solutions Limited (NSE: IKS) ("IKS Health"), a global leader in care enablement solutions. Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash for each share of common stock. The acquisition has been approved by the Boards of Directors of IKS Health, IKS, and TruBridge. The transaction is expected to close during the third calendar quarter of 2026, subject to the satisfaction of customary closing conditions, including the requisite shareholder approvals and the Hart-Scott-Rodino (HSR) notification and waiting period. First Quarter 2026 Highlights All comparisons are to the quarter ended March 31, 2025, unless otherwise noted Total bookings of $17.7 million compared to $17.3 million Total revenue of $86.3 million compared to $87.2 million Recurring revenue represented 94% of total revenue GAAP net income of $0.5 million compared to $0.5 million Non-GAAP net income of $8.5 million compared to $5.2 million Adjusted EBITDA of $16.5 million compared to $18.2 million Conference Call In light of the pending transaction with IKS, TruBridge will not host a conference call or webcast to discuss its first quarter 2026 financial results. About TruBridge TruBridge proudly supports rural and community hospitals and providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, TruBridge offers a mix of technology, services, and strategic expertise — including revenue cycle management (RCM), electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, personal care close to home. For more informati...

TruBridge (TBRG) reported Q1 non-GAAP earnings late Friday of $0.59 per share, up from $0.36 a year

MOBILE, Ala. (AP) — MOBILE, Ala. (AP) — TruBridge, Inc. (TBRG) on Friday reported net income of $506,000 in its first quarter. The Mobile, Alabama-based company said it had net income of 3 cents per share. Earnings, adjusted for one-time gains and costs, came to 59 cents per share. The healthcare information technology company posted revenue of $86.3 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBRG at https://www.zacks.com/ap/TBRG

TruBridge (TBRG) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.36 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +15.69%. A quarter ago, it was expected that this healthcare information technology company would post earnings of $0.41 per share when it actually produced earnings of $0.79, delivering a surprise of +92.68%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. TruBridge, which belongs to the Zacks Medical Info Systems industry, posted revenues of $86.27 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 3.62%. This compares to year-ago revenues of $87.21 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. TruBridge shares have added about 16.8% since the beginning of the year versus the S&P 500's gain of 7.2%. While TruBridge has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for TruBridge was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1...

Hinge Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Wall Street expects a year-over-year increase in earnings on higher revenues when TruBridge (TBRG) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. This healthcare information technology company is expected to post quarterly earnings of $0.51 per share in its upcoming report, which represents a year-over-year change of +41.7%. Revenues are expected to be $89.51 million, up 2.6% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 33.33% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant f...

TruBridge (TBRG) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company. The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this healthcare information technology company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight. The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008. For TruBridge, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year. The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate: The company is expected to earn $0.51 per share for the current quarter, which represents a year-over-year change of +41.7%. Over the last 30 days, the Zacks Consensus Estimate for TruBridge has increased 33.33% because one estimate has moved higher compared to no negative revisions. For the full year, the earnings estimate of $2.25 per share represents a change of -15.4% from the year-ago number. There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for TruBridge versus no negative revisions. This has pushed the consensus estimate 25.64% higher. The promising estimate revisions have helped TruBridge earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500. TruBridge shares have added 20.6% over the past four weeks, suggestin...

This article first appeared on GuruFocus. Release Date: March 31, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. TruBridge Inc (NASDAQ:TBRG) reported a 23% year-over-year increase in adjusted EBITDA, reaching $68.7 million for 2025. The company achieved a 1.4% increase in total revenue for the full year, amounting to $346.8 million. Free cash flow increased by $5 million over 2024, totaling $20 million for the year. TruBridge Inc (NASDAQ:TBRG) saw a significant 53% increase in the sales pipeline since the beginning of Q3, indicating strong market demand. The company successfully opened a new Global Capacity Center in Chennai, enhancing its cross-shore global delivery model. TruBridge Inc (NASDAQ:TBRG) experienced a 1% decrease in fourth-quarter revenue compared to the previous year. The company faced challenges with customer retention, particularly in its CBO segment, due to global workforce transitions. There was a delay in earnings timing due to the identification of material non-cash misstatements related to revenue timing. Patient Care revenue declined by 6.6% year-over-year, primarily due to the sunset of the Centric product. TruBridge Inc (NASDAQ:TBRG) is not providing formal guidance for 2026 due to an ongoing strategic review process. Warning! GuruFocus has detected 4 Warning Signs with TBRG. Is TBRG fairly valued? Test your thesis with our free DCF calculator. Q: Vinay, you mentioned the outlook for the year being modest revenue growth. Could you explain how the annual contract value (ACV) bookings metric helps in understanding your visibility? A: Unidentified_3 (CFO): You're on the right track. The recurring revenues and some assumption of bookings conversion can be applied to understand how bookings translate into revenue and attrition. That's the right way of doing it. Q: Did your retention rate in Q4 improve, and how does the number of renewals in 2025 compare to 2026? A: Unidentified_2 (CEO): It's not quite as many as we had in the target. The continuation of some attrition from '25 is playing into '26, with a modest improvement. We're focused on ensuring the process is right and monitoring metrics that matter most. Q: Any indication on timelines for the strategic review process? A: Unidentified_2 (CEO): We do not have a timeline. The Board is being thoughtful, focusing on shareholder v...

MOBILE, Ala. (AP) — MOBILE, Ala. (AP) — TruBridge, Inc. (TBRG) on Tuesday reported a loss of $5.5 million in its fourth quarter. The Mobile, Alabama-based company said it had a loss of 37 cents per share. Earnings, adjusted for one-time gains and costs, were 79 cents per share. The healthcare information technology company posted revenue of $87.2 million in the period. For the year, the company reported profit of $4.4 million, or 29 cents per share. Revenue was reported as $346.8 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBRG at https://www.zacks.com/ap/TBRG

TruBridge (TBRG) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +92.68%. A quarter ago, it was expected that this healthcare information technology company would post earnings of $0.4 per share when it actually produced earnings of $0.88, delivering a surprise of +120%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. TruBridge, which belongs to the Zacks Medical Info Systems industry, posted revenues of $87.19 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.5%. This compares to year-ago revenues of $87.36 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. TruBridge shares have lost about 36.6% since the beginning of the year versus the S&P 500's decline of 7.3%. While TruBridge has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for TruBridge was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zack...

MOBILE, Ala., March 31, 2026--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) ("TruBridge"), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter Financial 2025 Highlights All comparisons are to the quarter ended December 31, 2024, unless otherwise noted. Total bookings of $19.8 million compared to $14.3 million Total revenue of $87.2 million compared to $88.1 million Recurring revenue represented 94% of total revenue Financial Health revenue of $56.2 million compared to $55.0 million Financial Health revenue represented 65% of total revenue GAAP net loss of $5.5 million compared to net loss of $5.1 million Non-GAAP net income of $11.4 million compared to $1.1 million Adjusted EBITDA of $19.2 million compared to $17.9 million Full Year 2025 Financial Highlights All comparisons are to the year ended December 31, 2024, unless otherwise noted. Total bookings of $82.9 million compared to $82.1 million Total revenue of $346.8 million compared to $342.2 million Recurring revenue represented 94% of total revenue Financial Health revenue of $221.7 million compared to $217.4 million Financial Health revenue represented 64% of total revenue GAAP net income of $4.4 million compared to net loss of $20.9 million Non-GAAP net income of $38.5 compared to $4.6 million Adjusted EBITDA of $68.7 million compared to $55.9 million Commenting on the results, Chris Fowler, chief executive officer of TruBridge, stated, "Throughout 2025, we continued to improve the quality of our earnings and strengthen our operational foundation through cost management and execution of our offshoring strategy, resulting in ongoing margin enhancement. The organizational changes we have undertaken have positioned us to drive improved customer satisfaction and results for shareholders. "As we look to 2026, we remain focused on the fundamentals while strategically pursuing a targeted AI initiative across the organization to enhance our offerings, modernize our technology infrastructure, and deliver an improved customer experience. We're making steady progress on our operational priorities and remain committed to continuous improvement," concluded Fowler. We have been engaged in a strategic review process over the past several months with the assistance of outside...